View drug registration information details.
| Items | Registration information |
|---|
| ID | 575 |
|---|
| No | 575 |
|---|
| Brand Name | OGIVRI 150 |
|---|
| Ingredients | TRASTUZUMAB 150 MG |
|---|
| Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | STORE 2-8 C |
|---|
| Shelf Life | 4 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL/150 MG |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | L01XC03 |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | ADJUVANT BREAST CANCER, MATASTATIC BREAST CANCER, METASTATIC GASTRIC CANCER |
|---|
| Contraindications | NONE |
|---|
| Side Effects | FEVER, NAUSEA, VOMITING, INFUSION REACTION, DIARRHEA, INCREASED COUGH, HEADACHE, FATIQUE, DYSPNEA, RASH, NEUTROPENIA, ANEMIA AND MYALGIA |
|---|
| Unit Price | |
|---|
| EDL |
Yes |
|---|
| Description | STERILE, OFF WHITE TO PALE YELLOW, PRESERVATIVE-FREE LYOPHILIZED POWDER FOR INJECTION, FOR INTRAVENOUS ADMINISTRATION |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | BIOCON LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | KTK/28D/7/2006 |
|---|
| Import Registration Date | 2006-04-28 |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | 2021-06-02 |
|---|
| FDD Registration No | 03 I 5439/23 |
|---|
| FDD Registration Date | 2023-03-31 |
|---|
| Expiry Date | 2026-03-30 |
|---|
Back to drug list
|
